Drug Discovery Services Market
Drug Discovery Services Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Chemistry Services, Biology Services); By Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization); By Drug Type (Biologics, Small Molecule Drugs); By Therapeutic Area (Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Oncology, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Published Date: June 2023
- Report ID: BWC23487
- Available Format: PDF
- Page: 400
Report Overview
Increasing investments in drug R&D by pharmaceutical and biotechnology companies, advancements in technology, rising prevalence of chronic and infectious diseases, and growing outsourcing of drug discovery services are projected to propel the expansion of global drug discovery services market during the forecast period between 2023 and 2029.Global Drug Discovery Services Market - Industry Trends & Forecast Report, 2029
Global drug discovery services market size was estimated at USD 18.5 billion in 2022. During the forecast period between 2023 and 2029, the global drug discovery services market size is projected to grow at a CAGR of 15.2% reaching a value of USD 52.8 billion by 2029. Major growth drivers for the global drug discovery services market include increasing R&D investments, the growing prevalence of chronic diseases, technological advancements, and the trend of outsourcing drug discovery services. Increasing emphasis on research and development (R&D) activities by pharmaceutical companies and biotechnology firms. These organizations are investing heavily in drug discovery to develop innovative and effective therapies. As a result, there is a growing demand for drug discovery services to streamline the drug development process, improve success rates, and reduce time and cost associated with bringing a new drug to market.
Global Drug Discovery Services Market – Overview
Drug discovery services refer to a range of specialized services offered by contract research organizations (CROs), academic institutions, and other service providers to support the drug discovery process. These services aim to accelerate and enhance the identification, optimization, and development of potential drug candidates.
The services involve the screening of large compound libraries or databases to identify hits, which are compounds that show activity against a specific disease target. These hits undergo further optimization through medicinal chemistry techniques to enhance their potency, selectivity, and other drug-like properties.
Global Drug Discovery Services Market
Growth Drivers
Increasing Prevalence of Chronic Diseases
The rising burden of chronic diseases is a global health concern. According to the World Health Organization (WHO), chronic diseases account for the majority of deaths worldwide, with an estimated 71% of all deaths attributed to non-communicable diseases (NCDs). As the global population continues to grow and age, the incidence and prevalence of chronic diseases are expected to increase further. This necessitates the development of innovative and effective drugs to address the specific needs of patients with these conditions. The limited effectiveness of existing therapies for many chronic diseases creates a need for novel treatment options. While there have been significant advancements in the management of chronic diseases, there are still unmet medical needs and areas where current treatments fall short. Drug discovery services can assist in identifying new drug candidates and optimizing their efficacy, safety, and tolerability to address these gaps in therapy.
Restraints
High Failure Rates
Drug discovery is a complex and challenging process that involves extensive research and development efforts to identify and develop effective drug candidates. However, the majority of drug candidates that enter the development pipeline fail to reach the market for various reasons. These high failure rates pose several challenges and limitations for drug discovery services. The primary reason for the high failure rates is the inability of drug candidates to demonstrate sufficient efficacy and safety profiles during preclinical and clinical testing. Many drug candidates that show promise in early-stage studies fail to produce the desired therapeutic effects or exhibit unexpected toxicity or side effects during subsequent testing phases. This necessitates early identification and mitigation of potential efficacy and safety concerns through robust preclinical and clinical evaluation, which increases the time and cost of drug development.
Impact of COVID-19 on Global Drug Discovery Services Market
The COVID-19 pandemic disrupted the research and development activities of pharmaceutical and biotech companies. Lockdown measures, travel restrictions, and social distancing guidelines led to the closure of labs, reduced productivity, and delayed timelines. This affected the drug discovery process and the overall demand for drug discovery services. The urgent need to develop effective treatments and vaccines for COVID-19 diverted significant resources and attention from other therapeutic areas. Many pharmaceutical companies and contract research organizations (CROs) shifted their focus toward COVID-19-related research, leading to a slowdown in non-COVID drug discovery projects. Despite these challenges, the COVID-19 pandemic also highlighted the importance of drug discovery and accelerated innovation in the pharmaceutical industry. The crisis spurred collaborations, increased investment in research and development, and prompted the adoption of new technologies and approaches. As the world recovers from the pandemic, the drug discovery services market is expected to rebound and grow, driven by an increasing focus on healthcare and the need for novel therapeutics.
Global Drug Discovery Services Market
Segmental Coverage
Global Drug Discovery Services Market – By Drug Type
By drug type, the global drug discovery services market is bifurcated into biologics and small molecule drugs segments. During the period in analysis, the small molecule drugs segment is expected to hold a significant market share due to the simplicity of working with small compounds, their affordability, and the rising number of start-ups and new entrants concentrating on creating small-molecule therapies.
Global Drug Discovery Services Market – By Therapeutic Area
Based on therapeutic area, the drug discovery services market segmented into neurology, infectious & immune system diseases, digestive system diseases, oncology, and others. During the forecast period, the oncology segment is expected to hold a significant market share. Cancer is a complex disease with diverse molecular pathways and mechanisms. This complexity necessitates extensive research and development efforts to identify and develop effective therapies. Drug discovery services play a crucial role in understanding the underlying biology of cancer, identifying potential drug targets, and conducting preclinical and clinical trials for new oncology drugs. Pharmaceutical companies, biotech firms, and academic research institutions have made substantial investments in oncology research and development. The potential for high returns on investment, coupled with the pressing need for effective cancer treatments, has led to significant funding and resources being allocated to oncology drug discovery services.
Global Drug Discovery Services Market – By End User
Based on end user, the drug discovery services market segmented into pharmaceutical & biotechnology companies, academic institutes, and others. During the period in analysis, the pharmaceutical & biotechnology companies segment is expected to hold a significant market share. These companies typically have a robust pipeline of drug candidates in various stages of development. They continuously seek to expand their product portfolios and address unmet medical needs. By leveraging drug discovery services, they can accelerate the identification, validation, and optimization of potential drug candidates, thereby maintaining a competitive edge in the market.
Global Drug Discovery Services Market – By Region
By geography, the global drug discovery services market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Asia Pacific dominated the global drug discovery services market and is expected to continue to dominate over the forecast period. The APAC region has experienced significant growth in its pharmaceutical and biotechnology sectors. Countries like China and India have emerged as major hubs for drug discovery and development due to their large population, growing middle class, and increasing healthcare expenditures. This has fueled the demand for drug discovery services in the region.
Competitive Landscape
Major players operating in global drug discovery services market include General Electric, Eurofins Scientific, Syngene International Limited, Wuxi AppTec, Frontage Labs, Domainex, WIL Research Laboratories LLC, Shanghai Medicilon, Inc., Labcorp Drug Development, Jubilant Biosys Ltd., Evotec, Shanghai ChemPartner, Charles River Laboratories, Merck & Co. Inc., and Thermo Fisher Scientific Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In February 2023 - Pioneering Medicines, a project of Flagship Pioneering (US), and Charles River Laboratories (US), announced a multi-program agreement that will give Pioneering Medicines access to Charles River's Logica Al platform for the discovery of small-molecule pharmaceuticals.
-
In February 2023 - A multi-target integrated drug discovery agreement between Evotec SE and Related Sciences expanded their relationship. In order to address unmet patient requirements, the two businesses set out to choose, find, and create precisely tailored medications.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2022 |
Base Year – 2022 |
|
Estimated Year – 2023 |
|
Forecast Period – 2023–2029 |
|
Facts Covered |
Revenue in USD Billion |
Market Coverage |
North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, The Netherlands, Belgium, NORDIC Countries, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Philippines, Vietnam, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Peru, Colombia, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Qatar, Kuwait, Iran, South Africa, Nigeria, Kenya, Egypt, Morocco, Algeria, Rest of Middle East & Africa) |
Product/ Service Segmentation |
Type, Process, Drug Type, Therapeutic Area, End User, Region |
Key Players |
General Electric, Eurofins Scientific, Syngene International Limited, Wuxi AppTec, Frontage Labs, Domainex, WIL Research Laboratories LLC, Shanghai Medicilon, Inc., Labcorp Drug Development, Jubilant Biosys Ltd., Evotec, Shanghai ChemPartner, Charles River Laboratories, Merck & Co. Inc., Thermo Fisher Scientific Inc. |
By Type
-
Chemistry Services
-
Biology Services
By Process
-
Target Validation
-
Target Selection
-
Hit-To-Lead Identification
-
Candidate Validation
-
Lead Optimization
By Drug Type
-
Biologics
-
Small Molecule Drugs
By Therapeutic Area
-
Neurology
-
Infectious & Immune System Diseases
-
Digestive System Diseases
-
Oncology
-
Others
By End User
-
Pharmaceutical & Biotechnology Companies
-
Academic Institutes
-
Others
By Region
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East and Africa
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Global Drug Discovery Services Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Growing prevalence of chronic diseases
- Outsourcing of drug discovery activities
- Increasing R&D expenditure
- Restraints
- Stringent regulatory requirements
- High failure rates
- Opportunities
- Emergence of personalized medicine
- Increasing focus on rare diseases and orphan drugs
- Challenges
- Ethical concerns and public perception
- Growth Drivers
- Technology Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Drug Discovery Services Market Overview
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Type
- Chemistry Services
- Biology Services
- By Process
- Target Validation
- Target Selection
- Hit-To-Lead Identification
- Candidate Validation
- Lead Optimization
- By Drug Type
- Biologics
- Small Molecule Drugs
- By Therapeutic Area
- Neurology
- Infectious & Immune System Diseases
- Digestive System Diseases
- Oncology
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Academic Institutes
- Others
- By Region
- North America
- Europe
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East and Africa (MEA)
- By Type
- North America Drug Discovery Services Market
-
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- By Country
- United States
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Canada
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- United States
-
- Europe Drug Discovery Services Market
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- By Country
- Germany
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- United Kingdom
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Italy
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- France
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Spain
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Belgium
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Russia
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Germany
- Market Size & Forecast, 2019–2029
-
-
-
- The Netherlands
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Rest of Europe
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- The Netherlands
-
-
- Asia-Pacific Drug Discovery Services Market
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- By Country
- China
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- India
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Japan
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- South Korea
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Australia & New Zealand
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Indonesia
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Malaysia
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Singapore
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Vietnam
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Rest of APAC
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- China
- Market Size & Forecast, 2019–2029
- Latin America Drug Discovery Services Market
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- By Country
- Brazil
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Mexico
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Argentina
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Peru
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Rest of Latin America
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Brazil
- Market Size & Forecast, 2019–2029
- Middle East & Africa Drug Discovery Services Market
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- By Country
- Saudi Arabia
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- UAE
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Qatar
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Kuwait
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- South Africa
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Nigeria
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Algeria
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Rest of MEA
- By Type
- By Process
- By Drug Type
- By Therapeutic Area
- By End User
- Saudi Arabia
- Market Size & Forecast, 2019–2029
- Competitive Landscape
- List of Key Players and Their Offerings
- Global Drug Discovery Services Company Market Share Analysis, 2022
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships)
- Impact of Covid-19 on Global Drug Discovery Services Market
- Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- General Electric
- Eurofins Scientific
- Syngene International Limited
- Wuxi AppTec
- Frontage Labs
- Domainex
- WIL Research Laboratories LLC
- Shanghai Medicilon, Inc.
- Labcorp Drug Development
- Jubilant Biosys Ltd.
- Evotec
- Shanghai ChemPartner
- Charles River Laboratories
- Merck & Co. Inc.
- Thermo Fisher Scientific Inc.
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumptions & Limitations
- Qualitative Research
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 Global Drug Discovery Services Segmentation
Figure 2 Global Drug Discovery Services Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Global Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 5 Global Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 6 Global Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 7 Global Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 8 Global Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 9 Global Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 10 Global Drug Discovery Services Market Share, By Region, By Value, 2019–2029
Figure 11 North America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 12 North America Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 13 North America Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 14 North America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 15 North America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 16 North America Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 17 North America Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Figure 18 United States Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 19 United States Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 20 United States Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 21 United States Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 22 United States Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 23 United States Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 24 Canada Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 25 Canada Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 26 Canada Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 27 Canada Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 28 Canada Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 29 Canada Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 30 Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 31 Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 32 Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 33 Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 34 Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 35 Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 36 Europe Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Figure 37 Germany Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 38 Germany Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 39 Germany Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 40 Germany Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 41 Germany Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 42 Germany Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 43 United Kingdom Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 44 United Kingdom Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 45 United Kingdom Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 46 United Kingdom Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 47 United Kingdom Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 48 United Kingdom Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 49 Italy Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 50 Italy Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 51 Italy Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 52 Italy Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 53 Italy Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 54 Italy Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 55 France Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 56 France Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 57 France Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 58 France Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 59 France Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 60 France Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 61 Spain Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 62 Spain Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 63 Spain Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 64 Spain Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 65 Spain Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 66 Spain Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 67 Belgium Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 68 Belgium Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 69 Belgium Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 70 Belgium Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 71 Belgium Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 72 Belgium Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 73 Russia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 74 Russia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 75 Russia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 76 Russia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 77 Russia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 78 Russia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 79 The Netherlands Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 80 The Netherlands Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 81 The Netherlands Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 82 The Netherlands Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 83 The Netherlands Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 84 The Netherlands Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 85 Rest of Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 86 Rest of Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 87 Rest of Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 88 Rest of Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 89 Rest of Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 90 Rest of Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 91 Asia-Pacific Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 92 Asia-Pacific Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 93 Asia-Pacific Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 94 Asia-Pacific Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 95 Asia-Pacific Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 96 Asia-Pacific Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 97 Asia-Pacific Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Figure 98 China Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 99 China Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 100 China Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 101 China Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 102 China Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 103 China Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 104 India Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 105 India Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 106 India Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 107 India Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 108 India Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 109 India Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 110 Japan Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 111 Japan Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 112 Japan Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 113 Japan Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 114 Japan Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 115 Japan Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 116 South Korea Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 117 South Korea Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 118 South Korea Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 119 South Korea Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 120 South Korea Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 121 South Korea Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 122 Australia & New Zealand Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 123 Australia & New Zealand Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 124 Australia & New Zealand Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 125 Australia & New Zealand Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 126 Australia & New Zealand Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 127 Australia & New Zealand Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 128 Indonesia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 129 Indonesia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 130 Indonesia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 131 Indonesia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 132 Indonesia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 133 Indonesia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 134 Malaysia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 135 Malaysia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 136 Malaysia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 137 Malaysia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 138 Malaysia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 139 Malaysia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 140 Singapore Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 141 Singapore Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 142 Singapore Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 143 Singapore Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 144 Singapore Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 145 Singapore Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 146 Vietnam Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 147 Vietnam Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 148 Vietnam Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 149 Vietnam Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 150 Vietnam Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 151 Vietnam Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 152 Rest of APAC Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 153 Rest of APAC Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 154 Rest of APAC Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 155 Rest of APAC Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 156 Rest of APAC Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 157 Rest of APAC Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 158 Latin America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 159 Latin America Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 160 Latin America Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 161 Latin America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 162 Latin America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 163 Latin America Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 164 Latin America Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Figure 165 Brazil Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 166 Brazil Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 167 Brazil Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 168 Brazil Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 169 Brazil Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 170 Brazil Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 171 Mexico Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 172 Mexico Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 173 Mexico Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 174 Mexico Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 175 Mexico Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 176 Mexico Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 177 Argentina Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 178 Argentina Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 179 Argentina Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 180 Argentina Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 181 Argentina Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 182 Argentina Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 183 Peru Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 184 Peru Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 185 Peru Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 186 Peru Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 187 Peru Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 188 Peru Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 189 Rest of LATAM Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 190 Rest of LATAM Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 191 Rest of LATAM Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 192 Rest of LATAM Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 193 Rest of LATAM Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 194 Rest of LATAM Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 195 Middle East & Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 196 Middle East & Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 197 Middle East & Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 198 Middle East & Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 199 Middle East & Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 200 Middle East & Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 201 Middle East & Africa Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Figure 202 Saudi Arabia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 203 Saudi Arabia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 204 Saudi Arabia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 205 Saudi Arabia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 206 Saudi Arabia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 207 Saudi Arabia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 208 UAE Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 209 UAE Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 210 UAE Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 211 UAE Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 212 UAE Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 213 UAE Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 214 Qatar Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 215 Qatar Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 216 Qatar Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 217 Qatar Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 218 Qatar Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 219 Qatar Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 220 Kuwait Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 221 Kuwait Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 222 Kuwait Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 223 Kuwait Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 224 Kuwait Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 225 Kuwait Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 226 South Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 227 South Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 228 South Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 229 South Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 230 South Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 231 South Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 232 Nigeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 233 Nigeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 234 Nigeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 235 Nigeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 236 Nigeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 237 Nigeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 237 Nigeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 238 Algeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 239 Algeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 240 Algeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 241 Algeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 242 Algeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 243 Algeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Figure 244 Rest of MEA Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Figure 245 Rest of MEA Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Figure 246 Rest of MEA Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Figure 247 Rest of MEA Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Figure 248 Rest of MEA Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 249 Rest of MEA Drug Discovery Services Market Share, By End User, By Value, 2019–2029
List of Tables
Table 1 Global Drug Discovery Services Segmentation
Table 2 Global Drug Discovery Services Market Value Chain Analysis
Table 3 Company Market Size Analysis, 2022
Table 4 Global Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 5 Global Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 6 Global Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 7 Global Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 8 Global Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 9 Global Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 10 Global Drug Discovery Services Market Share, By Region, By Value, 2019–2029
Table 11 North America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 12 North America Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 13 North America Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 14 North America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 15 North America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 16 North America Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 17 North America Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Table 18 United States Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 19 United States Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 20 United States Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 21 United States Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 22 United States Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 23 United States Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 24 Canada Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 25 Canada Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 26 Canada Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 27 Canada Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 28 Canada Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 29 Canada Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 30 Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 31 Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 32 Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 33 Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 34 Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 35 Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 36 Europe Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Table 37 Germany Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 38 Germany Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 39 Germany Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 40 Germany Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 41 Germany Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 42 Germany Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 43 United Kingdom Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 44 United Kingdom Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 45 United Kingdom Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 46 United Kingdom Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 47 United Kingdom Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 48 United Kingdom Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 49 Italy Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 50 Italy Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 51 Italy Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 52 Italy Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 53 Italy Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 54 Italy Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 55 France Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 56 France Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 57 France Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 58 France Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 59 France Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 60 France Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 61 Spain Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 62 Spain Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 63 Spain Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 64 Spain Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 65 Spain Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 66 Spain Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 67 Belgium Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 68 Belgium Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 69 Belgium Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 70 Belgium Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 71 Belgium Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 72 Belgium Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 73 Russia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 74 Russia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 75 Russia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 76 Russia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 77 Russia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 78 Russia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 79 The Netherlands Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 80 The Netherlands Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 81 The Netherlands Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 82 The Netherlands Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 83 The Netherlands Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 84 The Netherlands Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 85 Rest of Europe Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 86 Rest of Europe Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 87 Rest of Europe Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 88 Rest of Europe Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 89 Rest of Europe Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 90 Rest of Europe Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 91 Asia-Pacific Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 92 Asia-Pacific Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 93 Asia-Pacific Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 94 Asia-Pacific Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 95 Asia-Pacific Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 96 Asia-Pacific Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 97 Asia-Pacific Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Table 98 China Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 99 China Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 100 China Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 101 China Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 102 China Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 103 China Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 104 India Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 105 India Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 106 India Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 107 India Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 108 India Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 109 India Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 110 Japan Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 111 Japan Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 112 Japan Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 113 Japan Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 114 Japan Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 115 Japan Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 116 South Korea Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 117 South Korea Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 118 South Korea Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 119 South Korea Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 120 South Korea Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 121 South Korea Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 122 Australia & New Zealand Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 123 Australia & New Zealand Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 124 Australia & New Zealand Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 125 Australia & New Zealand Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 126 Australia & New Zealand Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 127 Australia & New Zealand Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 128 Indonesia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 129 Indonesia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 130 Indonesia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 131 Indonesia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 132 Indonesia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 133 Indonesia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 134 Malaysia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 135 Malaysia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 136 Malaysia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 137 Malaysia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 138 Malaysia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 139 Malaysia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 140 Singapore Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 141 Singapore Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 142 Singapore Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 143 Singapore Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 144 Singapore Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 145 Singapore Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 146 Vietnam Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 147 Vietnam Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 148 Vietnam Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 149 Vietnam Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 150 Vietnam Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 151 Vietnam Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 152 Rest of APAC Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 153 Rest of APAC Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 154 Rest of APAC Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 155 Rest of APAC Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 156 Rest of APAC Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 157 Rest of APAC Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 158 Latin America Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 159 Latin America Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 160 Latin America Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 161 Latin America Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 162 Latin America Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 163 Latin America Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 164 Latin America Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Table 165 Brazil Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 166 Brazil Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 167 Brazil Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 168 Brazil Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 169 Brazil Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 170 Brazil Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 171 Mexico Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 172 Mexico Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 173 Mexico Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 174 Mexico Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 175 Mexico Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 176 Mexico Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 177 Argentina Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 178 Argentina Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 179 Argentina Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 180 Argentina Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 181 Argentina Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 182 Argentina Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 183 Peru Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 184 Peru Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 185 Peru Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 186 Peru Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 187 Peru Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 188 Peru Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 189 Rest of LATAM Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 190 Rest of LATAM Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 191 Rest of LATAM Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 192 Rest of LATAM Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 193 Rest of LATAM Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 194 Rest of LATAM Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 195 Middle East & Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 196 Middle East & Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 197 Middle East & Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 198 Middle East & Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 199 Middle East & Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 200 Middle East & Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 201 Middle East & Africa Drug Discovery Services Market Share, By Country, By Value, 2019–2029
Table 202 Saudi Arabia Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 203 Saudi Arabia Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 204 Saudi Arabia Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 205 Saudi Arabia Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 206 Saudi Arabia Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 207 Saudi Arabia Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 208 UAE Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 209 UAE Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 210 UAE Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 211 UAE Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 212 UAE Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 213 UAE Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 214 Qatar Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 215 Qatar Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 216 Qatar Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 217 Qatar Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 218 Qatar Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 219 Qatar Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 220 Kuwait Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 221 Kuwait Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 222 Kuwait Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 223 Kuwait Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 224 Kuwait Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 225 Kuwait Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 226 South Africa Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 227 South Africa Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 228 South Africa Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 229 South Africa Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 230 South Africa Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 231 South Africa Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 232 Nigeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 233 Nigeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 234 Nigeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 235 Nigeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 236 Nigeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 237 Nigeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 238 Algeria Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 239 Algeria Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 240 Algeria Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 241 Algeria Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 242 Algeria Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 243 Algeria Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 244 Rest of MEA Drug Discovery Services Market Size, By Value (USD Billion), 2019–2029
Table 245 Rest of MEA Drug Discovery Services Market Share, By Type, By Value, 2019–2029
Table 246 Rest of MEA Drug Discovery Services Market Share, By Process, By Value, 2019–2029
Table 247 Rest of MEA Drug Discovery Services Market Share, By Drug Type, By Value, 2019–2029
Table 248 Rest of MEA Drug Discovery Services Market Share, By Therapeutic Area, By Value, 2019–2029
Table 249 Rest of MEA Drug Discovery Services Market Share, By End User, By Value, 2019–2029
Table 250 General Electric Company Overview
Table 251 General Electric Financial Overview
Table 252 Eurofins Scientific Company Overview
Table 253 Eurofins Scientific Financial Overview
Table 254 Syngene International Limited Company Overview
Table 255 Syngene International Limited Financial Overview
Table 256 Wuxi AppTec Company Overview
Table 257 Wuxi AppTec Financial Overview
Table 258 Frontage Labs Company Overview
Table 259 Frontage Labs Financial Overview
Table 260 Domainex Company Overview
Table 261 Domainex Financial Overview
Table 262 WIL Research Laboratories LLC Company Overview
Table 263 WIL Research Laboratories LLC Financial Overview
Table 264 Shanghai Medicilon, Inc. Company Overview
Table 265 Shanghai Medicilon, Inc. Financial Overview
Table 266 Labcorp Drug Development Company Overview
Table 267 Labcorp Drug Development Financial Overview
Table 268 Jubilant Biosys Ltd. Company Overview
Table 269 Jubilant Biosys Ltd. Financial Overview
Table 270 Evotec Company Overview
Table 271 Evotec Financial Overview
Table 272 Shanghai ChemPartner Company Overview
Table 273 Shanghai ChemPartner Financial Overview
Table 274 Charles River Laboratories Company Overview
Table 275 Charles River Laboratories Financial Overview
Table 276 Merck & Co. Inc. Company Overview
Table 277 Merck & Co. Inc. Financial Overview
Table 278 Thermo Fisher Scientific Inc. Company Overview
Table 279 Thermo Fisher Scientific Inc. Financial Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.